Related Experiment Video
Updated: Mar 8, 2026

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
Published on: November 21, 2025
Cardioembolic Stroke
1From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute (H.K.) and Department of Neurology, Weill Cornell Medicine, New York, NY (H.K.); and Department of Medicine and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (J.S.H.). hok9010@med.cornell.edu.
Cardiac embolism is a growing cause of ischemic stroke. Strategies include identifying embolic stroke of undetermined source, often linked to subclinical atrial fibrillation or atrial cardiomyopathy, and using novel anticoagulants.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Cardiac embolism is an increasing cause of ischemic stroke.
- Many cryptogenic strokes may originate from embolism, leading to the concept of embolic stroke of undetermined source.
- Subclinical atrial fibrillation and atrial cardiomyopathy are increasingly recognized as sources of cardioembolic stroke.
Purpose of the Study:
- To review potential strategies for preventing the rise in cardioembolic stroke.
- To highlight the role of atrial fibrillation and atrial cardiomyopathy in stroke etiology.
- To discuss the application of novel anticoagulants and risk factor management.
Main Methods:
- Review of recent clinical trials and emerging evidence.
- Discussion of diagnostic approaches like prolonged heart rhythm monitoring.
- Analysis of therapeutic options including non-vitamin K antagonist oral anticoagulants.
Main Results:
- Embolic stroke of undetermined source is a distinct target for investigation.
- Subclinical atrial fibrillation and atrial cardiomyopathy are significant contributors to stroke.
- Non-vitamin K antagonist oral anticoagulants show promise in preventing cardioembolic stroke.
Conclusions:
- Early diagnosis of atrial fibrillation and management of atrial cardiomyopathy are crucial.
- Novel anticoagulants and comprehensive vascular risk factor management are key to reducing cardioembolic stroke.
- Improved imaging and anticoagulation strategies may prevent stroke from myocardial infarction and heart failure.
More Related Videos
Related Concept Videos
Pulmonary Embolism I: Introduction
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Peripheral Artery Disease I: Introduction
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

